AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,042,000 | +310.9% | 5,265,265 | +3639.5% | 2.57% | +13410.5% |
Q3 2014 | $497,000 | +25.2% | 140,800 | +196.4% | 0.02% | +11.8% |
Q2 2014 | $397,000 | +52.7% | 47,500 | +15.9% | 0.02% | +13.3% |
Q1 2014 | $260,000 | +60.5% | 41,000 | +80.2% | 0.02% | +50.0% |
Q4 2013 | $162,000 | – | 22,758 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |